These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7689439)
1. The future of the quinolones. Andriole VT Drugs; 1993; 45 Suppl 3():1-7. PubMed ID: 7689439 [TBL] [Abstract][Full Text] [Related]
2. The fluoroquinolones. Walker RC Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871 [TBL] [Abstract][Full Text] [Related]
3. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
4. The quinolones: decades of development and use. Emmerson AM; Jones AM J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699 [TBL] [Abstract][Full Text] [Related]
5. Quinolones in sexually transmitted diseases: state of the art. Ridgway GL Drugs; 1999; 58 Suppl 2():92-5. PubMed ID: 10553714 [TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolones: mechanism of action, classification, and development of resistance. Blondeau JM Surv Ophthalmol; 2004 Mar; 49 Suppl 2():S73-8. PubMed ID: 15028482 [TBL] [Abstract][Full Text] [Related]
7. The place of quinolones in everyday clinical practice. Moellering RC Chemotherapy; 1996 Mar; 42 Suppl 1():54-61. PubMed ID: 9091272 [TBL] [Abstract][Full Text] [Related]
8. The chemical and biological aspects of fluoroquinolones: reality and dreams. Bhanot SK; Singh M; Chatterjee NR Curr Pharm Des; 2001 Mar; 7(5):311-35. PubMed ID: 11254892 [TBL] [Abstract][Full Text] [Related]
9. Is more than one quinolone needed in clinical practice? Paladino JA Ann Pharmacother; 2001 Sep; 35(9):1085-95. PubMed ID: 11573860 [TBL] [Abstract][Full Text] [Related]
10. New classification and update on the quinolone antibiotics. King DE; Malone R; Lilley SH Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154 [TBL] [Abstract][Full Text] [Related]
11. Microbiologic aspects of fluoroquinolones. Neu HC Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268 [TBL] [Abstract][Full Text] [Related]
14. Risks associated with the therapeutic use of fluoroquinolones. Stahlmann R; Lode HM Expert Opin Drug Saf; 2013 Jul; 12(4):497-505. PubMed ID: 23651367 [TBL] [Abstract][Full Text] [Related]
15. Quinolones in the treatment of lower respiratory tract infections in adult patients. Carbon C Drugs; 1993; 45 Suppl 3():91-7. PubMed ID: 7689458 [TBL] [Abstract][Full Text] [Related]
16. Activity of newer fluoroquinolones in vitro against gram-positive bacteria. Eliopoulos GM Drugs; 1999; 58 Suppl 2():23-8. PubMed ID: 10553701 [TBL] [Abstract][Full Text] [Related]
18. [The present status and future perspectives of fluorinated quinolones from the aspect of clinical microbiology]. Lochmann O Cas Lek Cesk; 1997 Mar; 136(6):191-5. PubMed ID: 9221193 [TBL] [Abstract][Full Text] [Related]
19. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]. Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686 [No Abstract] [Full Text] [Related]
20. Clinical role of protein binding of quinolones. Bergogne-Bérézin E Clin Pharmacokinet; 2002; 41(10):741-50. PubMed ID: 12162760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]